SCHEMBL22268049

SCHEMBL22268049

C=CCn1ncc2c1C(=O)NC(O)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18834819 0.69 ADORA2B (0.36) —
SCHEMBL30861196 0.62 CYP3A4 (0.48) —
SCHEMBL11241808 0.62 GRIA1 (0.47) —
SCHEMBL31725530 0.61 SMN1; SMN2 (0.41) —
SCHEMBL10374777 0.59 HTT (0.44) —
SCHEMBL15384256 0.58 — —
SCHEMBL22119620 0.58 GDA (0.33) —
SCHEMBL7976363 0.57 HTT (0.30) —
SCHEMBL9674402 0.57 HTT (0.55) —
SCHEMBL7976361 0.56 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723741-B1 DNA polymerase IIIC inhibitors and use thereof ACURX PHARMACEUTICALS, LLC (US) 2020-07-28 — — US disclosed
Send feedback